Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06423911
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-05-16
Brief Title:
Study of Olverembatinib HQP1351 in Patients With CP-CML
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Organization Data
Organization:
Ascentage Pharma Group Inc
Class:
INDUSTRY
Study ID:
HQP1351CG301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascentage Pharma Group Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None